Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development

Documenti analoghi

• Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
  di: Wieczorek, Lindsay, et al.
  Pubblicazione: (2015)
• P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
  di: Chenine, A, et al.
  Pubblicazione: (2009)
• P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
  di: Matyas, GR, et al.
  Pubblicazione: (2009)
• Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines
  di: Matyas, Gary R., et al.
  Pubblicazione: (2010)
• Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140
  di: EMMER, Kristel L., et al.
  Pubblicazione: (2016)